Table 3 Characteristics of stroke participants
Characteristic | Total | Group1 | Group2 | Group3 | P value |
|---|---|---|---|---|---|
N = 1155 | N = 124 (N = 10.736%) | N = 691 (N = 59.827%) | N = 340 (N = 29.437%) | ||
M ± SD |  |  |  |  |  |
 Age (years) | 66.635 ± 11.335 | 61.370 ± 11.081 | 65.909 ± 11.215 | 70.046 ± 10.655 | < 0.001 |
 Follow-up time (months) | 65.205 ± 39.513 | 81.853 ± 43.527 | 68.519 ± 38.636 | 52.267 ± 36.017 | < 0.001 |
Gender, n% |  |  |  |  | < 0.001 |
 Male | 562 (43.373%) | 35 (22.944%) | 344 (45.781%) | 183 (45.591%) |  |
 Female | 593 (56.627%) | 89 (77.056%) | 347 (54.219%) | 157 (54.409%) |  |
Marriage, n% | Â | Â | Â | Â | 0.008 |
 Married | 551 (52.340%) | 54 (40.572%) | 337 (55.289%) | 160 (50.324%) |  |
 Non-married | 604 (47.660%) | 70 (59.428%) | 354 (44.711%) | 180 (49.676%) |  |
PIR, n% | Â | Â | Â | Â | 0.046 |
 Low < 1.3 | 421 (28.174%) | 53 (35.324%) | 261 (27.703%) | 107 (26.616%) |  |
 Medium1.3 ≥, < 3.5 | 543 (49.349%) | 57 (51.249%) | 316 (47.638%) | 170 (52.277%) |  |
 High ≥ 3.5 | 191 (22.477%) | 14 (13.427%) | 114 (24.659%) | 63 (21.107%) |  |
Diabetes, n% |  |  |  |  | < 0.001 |
 Yes | 397 (31.493%) | 35 (23.139%) | 218 (28.821%) | 144 (40.115%) |  |
 No | 758 (68.507%) | 89 (76.861%) | 473 (71.179%) | 196 (59.885%) |  |
Quartiles of TYG, n% |  |  |  |  | < 0.001 |
 Q1 (7.349–8.494) | 289 (25.320%) | 19 (13.934%) | 171 (25.270%) | 99 (29.491%) |  |
 Q2 (8.494–8.810) | 288 (24.140%) | 28 (22.995%) | 167 (22.659%) | 93 (27.674%) |  |
 Q3 (8.810–9.241) | 289 (26.187%) | 29 (24.358%) | 180 (27.423%) | 80 (24.231%) |  |
 Q4 (9.241–13.183) | 289 (24.354%) | 48 (38.713%) | 173 (24.648%) | 68 (18.604%) |  |
All-cause mortality |  |  |  |  | < 0.001 |
 Survival | 766 (69.968%) | 100 (78.113%) | 482 (73.692%) | 184 (59.205%) |  |
 Death | 389 (30.032%) | 24 (21.887%) | 209 (26.308%) | 156 (40.795%) |  |